Xishan Zhongke has a professional, stable, and experienced toxicology research technical team that can carry out a full range of preclinical safety evaluations, provide high-quality data and a rapid turnaround period to support various drug safety evaluation studies, and can quickly , timely and good communication feedback; can implement drug preclinical safety evaluation research that meets NMPA, FDA, ICH and other regulations and technical requirements, and complies with GLP specifications. Since its establishment, it has completed more than 1,000 safety evaluation services for more than 200 customers. The company fully uses Pristima data management system software to manage test data to ensure the authenticity, standardization and traceability of the data. Equipped with a professional SEND format conversion team, it can independently complete toxicological research data in SEND format for FDA application projects. Currently, it has completed SEND data conversion for more than 20 projects, of which 4 new drug projects have obtained clinical approval from the US FDA.